Genomic and therapy Anti-PCSK9 (evolocumab) for hypercolesteolemia

Slides:



Advertisements
Similar presentations
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning” A Report of the American College of Cardiology Foundation Task Force on Clinical.
Advertisements

Warfarin, Insulin and Digoxin are the most Dangerous drugs in the elderly. Do we believe that?
FDA Pharmacogenetic Labels A Clinical Perspective David A Flockhart MD, PhD Indiana University School of Medicine Clinical Pharmacology Subcommittee of.
Jean Amoura, MD, MSc Marvin L.Stancil, MD.  Evaluate how fetal, infant, and childhood development is critical to understanding chronic diseases among.
Principles of Drug Use in the Elderly Alastair Stephens Sophie Rozwadowski.
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
Dr AZZA ELSHERBINY Assistant professor of pharmacology.
University of Utah Department of Human Genetics Pharmacogenomics Louisa A. Stark, Ph.D. Director.
Pharmacologic Principles Chapter 1, 2, 3. Understanding Nurses must understand both + and – effects of drugs Pharmacotherapeutics –u–use of drugs and.
How and Why Drugs Work Chapter 5
Pharmacogenomics: advancing personalized medicine.
Factors Affecting Drug Activity Chapter 11 Pages
Integrating Scientific Advances into Regulation: Pharmacogenomics and Pharmacogenetics Janet Woodcock, M.D. Director, Center for Drug Evaluation and Research.
Medication/ Medication Administration
Prof. Flavia Franconi University of Sassari. Pharmacogenetics chronopharlacology Pharmacogenetics chronopharlacology Drugs Pharmacokinetics Modulators.
Pharmacogenomics Eric Jorgenson.
DR. SHABANA ALI (Associate Professor) FACTORS MODIFYING DRUG ACTONS.
Pharmacogenetics and Pharmacogenomics Eric Jorgenson 2/24/9.
+ Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013
Orientation to Pharmacology
MISTAKE IN PEDIATRIC PHARMACOTHERAPY Jarosław Woroń PharmD, PhD Chair Of Pharmacology, Dept. Of Clinical Pharmacology Jagiellonian University College of.
PharmacogeneticsPharmacogenetics Dr, P Derakhshandeh, PhD Dr, P Derakhshandeh, PhD.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 8 Individual Variation in Drug Responses.
GENES and TOBACCO USE. CAN GENES PREDICT WHO WILL… develop heart disease? develop lung cancer? become a smoker? be able to quit?
Pharmacogenetics & Pharmacogenomics Personalized Medicine.
Copyleft Clinical Trial Results. You Must Redistribute Slides The American College of Cardiology Foundation / American Heart Association Clopidogrel Recommendations.
Therapeutic drug Monitoring
Challenges to drug design Did you know? Over 2 million people are hospitalized each year for adverse reactions to prescription drugs. Over 2 million.
Introduction to Pharmacology Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.
How and Why Drugs Work Chapter 5. Intended and Unintended Effects of Drugs Intended responses: - Reason for using the drug Unintended responses: - Side.
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
Foundation Knowledge and Skills
Drug efficacy is questioned.. Variation in drug responses.
Section I General principle of Pharmacology. Where can you get information about general principle of Pharmacology?  Text books:  Katzung, Basic and.
Mega JL, et al. N Engl J Med 2009;360: Genetic Effects on Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel Mega JL, et al. N Engl J.
New research areas in personalised medicines
How and Why Drugs Work Chapter 5
Pediatric Pharmacotherapy Clinical Pearls
Common variants vs Rare variants
Chapter 5 Drug Metabolism
Chapter 9 PHARMACOKINETICS VARIABILITY
Factors Affecting Drug Activity
Endogenous and exogenous factors contribute to variability in drug effects physiological pathological genetic Goodman and Gilman, 2011.
By: Dr. Roshini Murugupillai
PHARMACODYNAMICS.
Pharmacogenomics Identification of genes variants that influence drug effects. Is it possible to predict the effect of a drug in a certain patient? Pharmacogenetics/genomics.
Enzymes involved in drug metabolism
Pharmacogenetic effects on pharmacokinetics and pharmacodynamics
Mahla sattarzadeh Kerman University of Medical Sciences
Factors affecting Drug Activity
Biopharmaceutics Dr Mohammad Issa Saleh.
Beatriz Pérez González 2017/18 Genomics
Clinical Pharmacokinetics
How and Why Drugs Work Chapter 5
Pharmacokinetics and Factors of Individual Variation
Conceptual Subdivisions of Pharmacology
CTD Module 4: Non-Clinical Studies SPC Relevant Scientific information
Conceptual Subdivisions of Pharmacology
Pharmacogenomics Genes and Drugs.
How and Why Drugs Work Chapter 5
FOURIER Trial design: Patients with established cardiovascular disease on statin therapy were randomized to evolocumab 140 mg subcutaneous every 2 weeks.
How and Why Drugs Work Chapter 5
Clinical Pharmacokinetics
Genomic and therapy Anti-PCSK9 (evolocumab) for hypercolesteolemia
Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:
Introduction to Pharmacogenetics
Drug Therapy in Pediatric Patients
Pharmacogenomics Identification of genes variants that influence drug effects. Is it possible to predict the effect of a drug in a certain patient? Pharmacogenetics/genomics.
POLYPHARMACY.
Presentation transcript:

Genomic and therapy Anti-PCSK9 (evolocumab) for hypercolesteolemia Identification of new drugs Anti-PCSK9 (evolocumab) for hypercolesteolemia Use of drugs in rare diseases Riboflavin to treat pathologies due to SLC52A2 deficiencies Dose adjustments TPMT polymorphysms and thiopurine dosing Predisposition to dose independent adverse effects HLA and predisposition to adverse effects Genomic and therapy

Endogenous and exogenous factors contribute to variability in drug effects physiological pathological genetic Goodman and Gilman, 2011

Variability can be defined as: pharmacokinetic pharmacodynamic idyosyncratic

Factors affecting variability in drug response Ethnic differences Age Pregnancy Diseases Drug interactions Genetic factors

Ethnic differences Ethnic means «belonging to a race». However many anthropologists are sceptical on the relevance of this concept. Afroamericans affected from cardiac insufficiency differently from Caucasians benefit from hydralizin and nitrate. Asiatics are more sensitive to the effects of propanolol and gefitinib, because of polymorphisms in drug targets.

Ethnic differences: drug metabolism

Ethnic differences: drug metabolism

Ethnic differences Ethnic group can be considered a surrogate of typing particular variants, also involved in drug pharmacokinetics and pharmacodynamics. However it is an approximation, therefore it is better to type directly the polymorphisms, because diversity in each ethnic group is ample.

Age Age is one of the main factors affecting response to pharmacological therapy. Children and elders present reduced drug elimination and are therefore more sensitive to drugs. For elders also physiological (alteration of cardiovascular reflexes, increase in body fat) and pathological (hypothermia, polytherapy) factors are relevant for drug response.

Age and drug excrection

Age and pharmacotherapy: pediatric patients Pediatrics does not deal with miniature men and women, with reduced doses and the same class of disease in smaller bodies, but has its own independent range and horizon. Dr. Abraham Jacobi

Age and pharmacotherapy: pediatric patients Kearns GL et al. N Engl J Med 2003;349:1157-1167.

Epigenetic (promoter methylation) can explain age-related changes in gene expression Kacevska et al., Biochimie 2012

Examples Cloramphenicol and sulphamidic intolerance in children due to reduced glucuronidation Morphine is not used among analgesis during delivery. «Gasping syndrome» in newborns due to benzylic alchool.

Pregnancy

Pregnacy and cytochromes

Fluoxethine biotransformation

Drugs can induce expression of metabolizing enzymes

Treatment Outcome (same dose) Personalized therapy Treatment Outcome (same dose) Responder No effect Adverse event                        

Drug effects Goodman and Gilman, 2011

Dose dependent side effects: morphine

Dose dependent «off target» adverse events: paracetamol

Drugs that can give hypersensitivity reactions in humans

Hypersensitivity reactions

Ipotesi del meccanismo delle reazioni di ipersensibilità "Hapten" "Pharmacological interaction" "Danger"

Hapten hypothesis

Pharmacological interaction

Danger hypothesis